Search Results

You searched for : Glenmark  

9th Edition of the India Health and Wellness Awards 2024 Celebrate Excellence in Healthcare, Innovations in Health and Patient Centric Approach Recognised

The awards ceremony also featured insightful keynote addresses, panel discussions, and networking opportunities, providing attendees with valuable insights and opportunities for collaboration....
Apr 27

Glenmark Launches Zita DM: A Triple-Drug Combination for Type 2 Diabetes for just Rs 14

Glenmark's commitment to providing affordable and effective solutions highlights its role as a leader in diabetes care. As Zita DM becomes a part of ...
Oct 19

International Women’s Day IWD 2022- Break The Bias- Gender equality today for a sustainable tomorrow

From business leaders to entrepreneurs, women are setting motivational examples for all of us. On the occasion of International Women’s Day 2022, Medicircle took ...
Mar 12

Dr. Aparna Das is enabling artificial intelligence to power healthcare ecosystem through Jatayu Healthcare Technologies

Dr. Aparna Das talks about Jatayu Healthcare Technologies. They have pocket-friendly, speech-based technology platforms using AI, ML, and NLP technologies to transform the ...
Jan 11

The success story behind Glenmark

The story begins in 1977. Saldanha starts a pharmaceutical company named after his two sons - Glenn and Mark. This is the beginning of a global ...
Sep 18

Growth of India’s Pharmaceutical Companies

Imagine the year 1969. In our domestic pharmaceutical market, Indian companies had a share of a mere 5%. Cut to last year where they had ...
Sep 16

Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib Capsules, 100 mg and 150 mg

According to IQVIATM sales data for the 12 month period ending April 2021, the Ofev Capsules, 100 mg and 150 mg market achieved annual sales ...
Jun 25

Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution

...
Jun 23

Glenmark launches Tiogiva, becoming one of the first companies in the UK to launch a bioequivalent version of Tiotropium Bromide dry powder inhaler

Glenmark has launched Tiotropium Bromide Dry Powder Inhaler (DPI) under the brand name - Tiogiva in UK ...
Jun 15

Glenmark’s launches Ryaltri innovative single nasal spray in Russia

...
Feb 23

Top Ten Mid Cap Indian Pharma Stocks ; January 2021

Top ten mid cap Indian pharma stocks , January 2021...
Jan 07

Top Ten Pharma Companies of India : January 2021

Top ten pharma stocks January 2021...
Jan 06

Glenmark receives ANDA final approval for Tadalafil Tablets

Glenmark has also received tentative approval by the U.S. FDA for Gabapentin Enacarbil Extended-Release Tablets, the generic version of Horizant 1of Arbor Pharmaceuticals....
Dec 31

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris Nasal Spray

...
Dec 23

Glenmark collaborates with Menarini for commercializing Ryaltris nasal spray across Europe

The licensing agreement will be effective in 33 countries throughout the European region including France, Italy, and Spain...
Dec 23

Glenmark Pharmaceuticals receives ANDA tentative approval for Dabigatran Etexilate Capsules

Glenmark has received tentative approval by the United States Food & Drug Administration for Dabigatran Etexilate Capsules, the generic version of Pradaxa 1 Capsules...
Dec 21

Glenmark Pharmaceuticals receives ANDA tentative approval for Axitinib Tablets

According to IQVIA sales data for the 12 month period ending October 2020, the Inlyta Tablets market achieved annual sales of approximately $518.8 million*....
Dec 01

Dr Reddy’s buys select anti-allergy brands from Glenmark in Russia and other CIS countries

Glenmark to launch Ryaltris, their global anti-allergy brand, in Russia and other CIS countries after the divestment ...
Nov 30

Glenmark Pharmaceuticals secures its position in the prestigious Dow Jones Sustainability Emerging Markets Index

DJSI is one of the world’s most respected and widely accepted sustainability benchmarks globally with only the top-ranked companies in terms of Corporate ...
Nov 26

Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure

The oral antiviral medication Favipiravir, which prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with ...
Nov 23

Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules

Glenmark has been granted final approval by the U.S. FDA for Tacrolimus Capsules USP, the generic version of Prograf Capsules, of Astellas Pharm US, ...
Nov 11

No significant clinical benefit with Umifenovir addition in COVID-19 treatment: Glenmark clinical study

Umifenovir did not show superior clinical outcomes when added to Favipiravir treatment. The trial did not meet key end-points ...
Oct 21

Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg

Glenmark received approval from ANDA for Sirolimus Tablets, a generic version of Rapamune Tablets...
Oct 19

Glenmark introduces a generic version of NINDANIB for the treatment of Pulmonary Fibrosis

Glenmark being a leader in the area of respiratory has been amongst the first to launch the branded generic version for the treatment of Pulmonary ...
Oct 14

Glenmark Pharmaceuticals receives ANDA approval for Dimethyl Fumarate Delayed-Release Capsules

Glenmark Pharmaceuticals Inc., USA has been granted final approval by the U.S. FDA for Dimethyl Fumarate DR Capsules, the generic version of Tecfidera...
Oct 07

25 Matching result(s) found!

-Advertisements-




Trending Now

A New Dawn for Eye Health in Obesity: How Bariatric Surgery Repairs Early Eye DamageDecember 14, 2024
Healing Invisible Wounds: How Indian Government’s Bold Initiatives Are Tackling the Mental Health CrisisDecember 14, 2024
The 8-Hour Miracle: Here’s How Doctors Rewrote a Young Girl’s FateDecember 14, 2024
University of Manchester invites applications for MSc Climate Change: Science, Society and Solutions December 13, 2024
Pollution vs. Population: Can India Survive Its Toxic Air?December 13, 2024
New Milestone: First Cryopreserved Stem Cell Donation Helps Blood Cancer Patient December 13, 2024
Everest Medicines Announces the First Prescription of VELSIPITY(R) Issued in MacauDecember 13, 2024
Plastic Pollution Goes Personal: Microplastics Found in Human BloodDecember 12, 2024
The Fat-Fuelled Weapon Against Cancer: How the Keto Lifestyle is Redefining Cancer TherapyDecember 12, 2024
Gene Therapy in India: How Indian Scientists Redefined Hemophilia TreatmentDecember 12, 2024
Empowering India’s Workforce: FinX Raises $6M from Elevar Equity to revolutionise employability in the BFSI IndustryDecember 12, 2024
India’s Win Over Malaria: A Global Health Victory in ProgressDecember 11, 2024
TB-Free India by 2025: Bold Vision or Achievable Reality?December 11, 2024
Aakash Healthcare Supports the 14th Special Athletic Meet for Children with Special NeedsDecember 11, 2024
The University of Manchester invites applications for an MSc in International Disaster ManagementDecember 10, 2024
Preventing Mother-to-Child HIV Transmission: Strategies and ImportanceDecember 10, 2024
USIBC Signs MOU with Government of Telangana, Hosts AI and GCC Industry RoundtableDecember 10, 2024
CarDekho Group’s New Auto Segment’s Shift in Fuel Preferences Report: Electric Vehicles (EVs) Lead the Chart with 26% YoY Traffic Increase December 10, 2024
India’s leading eCommerce enablement platform Shiprocket appoints industry veteran Vivek Sharma as VP of International ShippingDecember 10, 2024
Failure to find all TB cases defeats us in #endTB effortsDecember 10, 2024